Upgrade to SI Premium - Free Trial

Tonix Pharma (TNXP)

11.63 +0.11 (0.95%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC June 15, 2026 5:44 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: Jun 12 Filed by: Taylor Carolyn E. June 15, 2026 7:00 AM - SEC Filing Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 June 11, 2026 7:00 AM - Globe NewsWire Form 4 Tonix Pharmaceuticals For: Jun 08 Filed by: Stillwell Richard Newcomb June 9, 2026 5:30 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: Jun 09 Filed by: LEDERMAN SETH June 9, 2026 5:30 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Jun 08 June 8, 2026 7:05 AM - SEC Filing Tonix Pharmaceuticals expands TONMYA coverage to 52 million lives June 8, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives June 8, 2026 7:00 AM - Globe NewsWire Tonix Pharmaceuticals presents fibromyalgia opioid use data at medical meeting May 28, 2026 4:31 PM - StreetInsider Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meet May 28, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 27 May 27, 2026 7:06 AM - SEC Filing Tonix publishes phase 1 data for TNX-1500 transplant rejection drug May 27, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology May 27, 2026 7:00 AM - Globe NewsWire Tonix presents fibromyalgia patient data at ISPOR meeting May 26, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2 May 26, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P. May 15, 2026 4:30 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: May 15 May 15, 2026 9:26 AM - SEC Filing Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP May 15, 2026 8:06 AM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Stillwell Richard Newcomb May 14, 2026 5:49 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: OLUKOTUN ADEOYE Y May 14, 2026 5:48 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Bell Margaret Smith May 14, 2026 5:47 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Hunter James Randolph Jr May 14, 2026 5:46 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Treco James May 14, 2026 5:46 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: GRANGE DAVID L May 14, 2026 5:44 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: BAGGER RICHARD H May 14, 2026 5:43 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Taylor Carolyn E. May 14, 2026 5:42 PM - SEC Filing Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026 May 14, 2026 7:00 AM - Globe NewsWire Tonix Pharmaceuticals to Participate in Two Investor Conferences in May May 12, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 11 May 11, 2026 5:18 PM - SEC Filing Form 10-Q Tonix Pharmaceuticals For: Mar 31 May 11, 2026 5:16 PM - SEC Filing Tonix Pharma (TNXP) Misses Q1 EPS by 35c May 11, 2026 4:33 PM - StreetInsider Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights May 11, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 07 May 7, 2026 5:21 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: May 06 May 6, 2026 7:06 AM - SEC Filing Tonix secures coverage for fibromyalgia drug for 35 million patients May 6, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients May 6, 2026 7:00 AM - Globe NewsWire TD Cowen Starts Tonix Pharma (TNXP) at Buy May 4, 2026 5:30 AM - StreetInsider Form 8-K Tonix Pharmaceuticals For: May 01 May 1, 2026 4:58 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Apr 29 April 29, 2026 7:05 AM - SEC Filing Tonix plans Phase 2 study of Lyme disease prevention drug TNX-4800 April 29, 2026 7:00 AM - StreetInsider Tonix plans phase 2 study of lyme disease prevention drug by 2027 April 29, 2026 7:00 AM - StreetInsider Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at th April 29, 2026 7:00 AM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: Apr 21 April 23, 2026 7:12 AM - SEC Filing Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 April 23, 2026 7:02 AM - Globe NewsWire Tonix publishes TONMYA pharmacokinetics study in peer-reviewed journal April 15, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development April 15, 2026 7:00 AM - Globe NewsWire Form 4 Tonix Pharmaceuticals For: Mar 31 Filed by: LEDERMAN SETH April 1, 2026 9:31 AM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Mar 30 March 31, 2026 7:06 AM - SEC Filing Tonix presents phase 1 data for Lyme disease prevention drug TNX-4800 March 31, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington March 31, 2026 7:01 AM - Globe NewsWire Form DEF 14A Tonix Pharmaceuticals For: May 07 March 30, 2026 8:01 AM - SEC Filing Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: VANGUARD GROUP INC March 27, 2026 1:32 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Mar 26 March 26, 2026 7:01 AM - SEC Filing Tonix starts dosing patients in migraine drug study March 26, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine March 26, 2026 7:00 AM - Globe NewsWire Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 March 23, 2026 4:32 PM - Globe NewsWire Form PRE 14A Tonix Pharmaceuticals For: May 07 March 20, 2026 5:13 PM - SEC Filing Full Article List